跳至主要内容
临床试验/NCT01772602
NCT01772602招募中不适用

The National Amyotrophic Lateral Sclerosis Registry

Centers for Disease Control and Prevention2 个研究点 分布在 1 个国家目标入组 30,000 人开始时间: 2010年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
30,000
试验地点
2
主要终点
The National Amyotrophic Lateral Sclerosis (ALS) Registry

研究概览

简要总结

The purpose of this registry is to (A) better describe the incidence and prevalence of Amyotrophic Lateral Sclerosis (ALS) in the United States;(B) examine appropriate factors, such as environmental and occupational, that may be associated with the disease; (C) better outline key demographic factors (such as age, race or ethnicity, gender, and family history of individuals who are diagnosed with the disease) associated with the disease; and (D) better examine the connection between ALS and other motor neuron disorders that can be confused with ALS, misdiagnosed as ALS, and in some cases progress to ALS.

详细描述

The National ALS Registry's Research Notification System allows person with ALS to participate in clinical trials.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - U.S. citizens 18 years of age or older

排除标准

  • 未提供

结局指标

主要结局

The National Amyotrophic Lateral Sclerosis (ALS) Registry

时间窗: 1 year

To determine the incidence and prevalence of Amyotrophic Lateral Sclerosis in the US.

次要结局

  • Risk factors of ALS(1 year)

研究者

申办方类型
Fed
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验